NEPTUNE DIGITAL ASSETS CORP
NPPTF
Intchains Group
ICG
Bitdeer Technologies
BTDR
BIGG DIGITAL ASSETS INC
BBKCF
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
ATXS Astria Therapeutics Inc
- 10.230
- -0.140-1.35%
Close Dec 3 16:00 ET
- 10.230
- 0.0000.00%
Post 20:01 ET
577.32MMarket Cap-4692P/E (TTM)
10.350High9.990Low397.35KVolume10.350Open10.370Pre Close4.03MTurnover1.30%Turnover RatioLossP/E (Static)56.43MShares16.90052wk High2.34P/B313.18MFloat Cap4.97052wk Low--Dividend TTM30.61MShs Float1017.600Historical High--Div YieldTTM3.47%Amplitude2.360Historical Low10.147Avg Price1Lot Size
Astria Therapeutics Inc News
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
TD Cowen Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $35
Astria Therapeutics (NASDAQ:ATXS) Is In A Good Position To Deliver On Growth Plans
A Quick Look at Today's Ratings for Astria Therapeutics Inc(ATXS.US), With a Forecast Between $23 to $35
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Astria Therapeutics Analyst Ratings
Express News | Astria Therapeutics : Oppenheimer Raises Target Price to $28 From $26
H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16
Express News | Astria Therapeutics Q3 EPS $(0.42) Misses $(0.41) Estimate
Astria Expects Cash, Cash Equivalents and Short-Term Investments as of Sept 30 Sufficient to Fund Ops Into Mid-2027 >ATXS
Astria Therapeutics: Final 3- and 6-Mo Results From ALPHA-STAR Trial of Navenibart Expected in 4Q
Astria Therapeutics: Phase 1a Trial of STAR-0310 in Healthy Subjects Expected to Initiate in Q1 2025 >ATXS
Astria Therapeutics 3Q Loss/Shr 42c >ATXS
Astria Therapeutics 3Q Loss $24.5M >ATXS
Express News | Astria Therapeutics Inc - as of September 30, 2024, Astria Had Cash, Cash Equivalents and Short-Term Investments of $344.3 Mln
Press Release: Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Express News | Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Express News | Astria Therapeutics Q3 Income From Operations USD -29.014 Million
Express News | Astria Therapeutics Q3 Operating Expenses USD 29.014 Million
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.